In the past week, NXTC stock has gone down by -17.83%, with a monthly decline of -34.52% and a quarterly surge of 8.40%. The volatility ratio for the week is 12.51%, and the volatility levels for the last 30 days are 12.96% for Nextcure Inc The simple moving average for the past 20 days is -31.94% for NXTC’s stock, with a -10.57% simple moving average for the past 200 days.
Is It Worth Investing in Nextcure Inc (NASDAQ: NXTC) Right Now?
The 36-month beta value for NXTC is at 0.49. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NXTC is 21.15M, and currently, shorts hold a 0.54% of that float. The average trading volume for NXTC on April 26, 2024 was 281.44K shares.
NXTC) stock’s latest price update
Nextcure Inc (NASDAQ: NXTC)’s stock price has dropped by -10.42 in relation to previous closing price of 1.44. Nevertheless, the company has seen a loss of -17.83% in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-02 that BELTSVILLE, Md., April 02, 2024 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it will present at the 23rd Annual Needham Virtual Healthcare Conference on Thursday, April 11th, at 12:45 pm ET.
Analysts’ Opinion of NXTC
Ladenburg Thalmann, on the other hand, stated in their research note that they expect to see NXTC reach a price target of $16. The rating they have provided for NXTC stocks is “Buy” according to the report published on March 01st, 2022.
Truist gave a rating of “Buy” to NXTC, setting the target price at $19 in the report published on March 05th of the previous year.
NXTC Trading at -25.06% from the 50-Day Moving Average
After a stumble in the market that brought NXTC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -49.81% of loss for the given period.
Volatility was left at 12.96%, however, over the last 30 days, the volatility rate increased by 12.51%, as shares sank -33.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.27% lower at present.
During the last 5 trading sessions, NXTC fell by -17.83%, which changed the moving average for the period of 200-days by -27.12% in comparison to the 20-day moving average, which settled at $1.8630. In addition, Nextcure Inc saw 13.16% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NXTC
The total capital return value is set at -0.55. Equity return is now at value -44.49, with -39.81 for asset returns.
Based on Nextcure Inc (NXTC), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at -8.02. The debt to equity ratio resting at 0.06. The interest coverage ratio of the stock is 69.37.
Currently, EBITDA for the company is -63.95 million with net debt to EBITDA at 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 16.38.
Conclusion
In conclusion, Nextcure Inc (NXTC) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
